Advertisement

Topics

Latest "TD Ameritrade Holding Corporation" News Stories

19:49 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "TD Ameritrade Holding Corporation" found in our extensive news archives from over 250 global news sources.

More Information about TD Ameritrade Holding Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about TD Ameritrade Holding Corporation for you to read. Along with our medical data and news we also list TD Ameritrade Holding Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of TD Ameritrade Holding Corporation Companies for you to search.

Showing "Ameritrade Holding Corporation" News Articles 1–25 of 1,500+

Monday 10th December 2018

S&U (SUS) - Trading broadly in line

Edison Investment Research - Financials - S&U: S&U’s latest trading update indicates it is on track to deliver results close to expectations for the current year. Motor finance receivables growth slowed in the second half, which prompted a reduction in our estimates, primarily for FY20. We still look for a return on equity (ROE) of above 17% and believe the discipline shown in holding to...


Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder

Novartis International AG / Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. reSET-OTM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics...

Auris Medical Holding AG EARS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAuris Medical Holding AG Auris Medical is a clinicalstage biopharmaceutical company with focus on neurotology and mental health supportive care. The company's pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, postacute inner ear tinnitus, tinnitus, Meniere's disease Vertigo, sudden loss of hearing, antipsychoticinduced weight ...


Seasoned IT Executive Joseph Pekala Joins Owens & Minor as Chief Information Officer

Owens & Minor, Inc. (NYSE: OMI) announced today the appointment of Joseph S. Pekala as Senior Vice President & Chief Information Officer (CIO), effective December 10, 2018. Pekala will serve on Owens & Minor’s leadership team, reporting directly to Robert C. Sledd, Chairman and Interim President & CEO. As CIO, Pekala will ...

Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018

Santhera Pharmaceuticals Holding AG / Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 10, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that its Board o...

RAC Corporation Opens New Research and Development Facility in Southern California

“Strategic Growth and Development in Dental Lab Businesses” RAC Corporation recently opened its doors to provide unique and cutting-edge solutions for its clients in the dental and biotechnology industries. RAC specializes in building turn-key production plants that produce the highest-quality Zirconia disks in the most cost-effective way...

Inventiva invited to present at the 37th Annual J.P. Morgan Healthcare Conference

                                                Inventiva invited to present at the 37th Annual J.P. Morgan Healthcare Conference Daix (France), December 10, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH),...

DHL Express Saudi, Astrazeneca Saudi, Hilti Saudi and Asala Holding Recognized as the Top Four Best Places To Work in Saudi for 2018

RIYADH, Saudi Arabia, December 10, 2018 /PRNewswire/ -- DHL Express Saudi, Astrazeneca Saudi, Hilti Saudi and Asala Holding were awarded the Best Place To Work certification in Saudi Arabia for 20...

Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine

DUBLIN - December 10, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st on this year's JUST 100: America&...

2019 EP & Clean Tech China to Gather Well-known Pharmaceutical Enterprises, EP Equipment Providers

Hosted by UBM Sinoexpo SHANGHAI, Dec. 10, 2018 /PRNewswire/ -- EP & Clean Tech China, hosted by CCCMHPIE, UBM EMEA and UBM Sinoexpo, is an annual event of the pharmaceutical EP industry. The event will be held in Hall N4 of Shanghai New International Expo Centre (SNIEC) between June 18-20, 2019 along with CPhI & P-MEC China 2019. It will provide green...

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

Press release December 10, 2018 Appeal on Enzymatica's cold spray in Germany overruled Enzymatica has been informed that the Frankfurt Higher Regional Court - OLG (Oberlandesgericht) has overruled the appeal on a previous court ruling regarding the marketing of the mouth spray ViruProtect® in Germany. The OLG court claims that no new information has been brought forward t...

EOS imaging Completes €15M Capital Raise Entirely Subscribed by Fosun Pharmaceutical AG

EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (Paris:EOSI) ("EOS imaging" or the "Company"), the pioneer of 2D/3D imaging and data solutions for orthopedics, previously announced in a press release dated July 17th, 2018 having entered into a binding agreement (the "Subscription Agreement") with Fosun Pharmac...

Gilead names Roche veteran Daniel O'Day as new CEO

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role as CEO alongside Chairman Dr John Martin, it has emerged that Daniel O’ Day, current CEO of Roche’s pharmaceutical business, will be stepping in to helm the company. O’ Day has been with Roche since 1987, holding a number of roles in the US, before moving to the company’s headquar...

German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity

Press release Malmö, Sweden 10th of December 2018 German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity After three months of strong results using Acarix's CADScor®System to evaluate potential coronary artery disease, Dr Katarina Varga, who operates two clinics in Seifhennersdorf, Germany, has ordered her second system to evaluate even more patients wh...

Opinion: What’s holding pharma back from the next antibiotic breakthrough?

Reinvigorating the commercial model for bringing new antibiotics to market is essential, but that could prove as difficult as eradicating superbugs.

Gilead grabs Roche vet as CEO

Gilead Sciences has named Roche Holding's Daniel O’Day as its new chief executive.

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018

Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 10, 2018) As of December 5, 2018, shares and voting rights outstanding of EssilorLuxottica, the global...

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 10, 2018) As of November 30, 2018, shares and voting rights outstanding of EssilorLuxottica, the globa...

Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study

NEW HAVEN, Conn., Dec. 10, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced initial positive results from its ongoing long-term, open-label Read more...

Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea

Basilea Pharmaceutica AG / Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, Switzerland, December 10, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announc...

New member proposed for election to Roche Board of Directors

F. Hoffmann-La Roche Ltd / New member proposed for election to Roche Board of Directors . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors (BoD) of Roche Holding Ltd decided on first pr...

Changes to the Roche Corporate Executive Committee

F. Hoffmann-La Roche Ltd / Changes to the Roche Corporate Executive Committee . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be s...

Roche Names William Anderson CEO, Roche Pharmaceuticals

SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG (RHHBY) announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role...

Germany Dental Devices Market Outlook to 2025 Dental CAD/CAM Systems and Materials, Crown and Bridge Materials, Dental Equipment, Dental Hygiene Devices, and Others [Report Updated: 01102018] Prices from USD $5096

Germany Dental Devices Market Outlook to 2025 Dental CAD/CAM Systems and Materials, Crown and Bridge Materials, Dental Equipment, Dental Hygiene Devices, and OthersSummaryGlobalData's new report, Germany Dental Devices Market Outlook to 2025, provides key market data on the Germany Dental Devices market. The report provides value, in millions of US dollars, volume in units and average prices USD ...

Gilead Sciences hires Roche executive Daniel O'Day as CEO

Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O'Day as its new chief executive officer, the companies said on Monday.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks